Research theme for competitive and other funds (11):
2022 - 2025 Elucidation of the diversity of canine mammary tumors and the foundation of cancer stem cell-targeted therapies
2021 - 2024 Characteristic analysis of canine mesenchymal stem cells capable of differentiating into insulin-producing cells and establishment of transplantation therapy
2019 - 2022 Understanding of the pathogenic mechanism of canine mammary cancer using organoid culture and construction of the foundation for cancer stem cell-target therapy
2015 - 2018 肥満細胞腫におけるチロシンキナーゼ阻害剤耐性化機構の解明と克服戦略の構築
2014 - 2017 Basic study of a long non-coding RNA, H19, as a novel therapeutic target for pancreatic cancer
Tomokazu Nagashima, Masanori Kobayashi, Yoshiaki Kubo, Katsuya Nagaho, Kayoko Sugibayashi, Takahiro Saito, Yukino Machida, Masaki Michishita. Prostatic stromal tumour of uncertain malignant potential in a dog. Journal of Comparative Pathology. 2024. 210. 8-14
yuyo yasumura, Takahiro Teshima, Tomokazu Nagashima, Masaki Michishita, Takashi Takano, Yoshiaki Taira, Ryohei Suzuki, Hirotaka Matsumoto. Immortalized Canine Adipose-Derived Mesenchymal Stem Cells Maintain the Immunomodulatory Capacity of the Original Primary Cells. International Journal of Molecular Sciences. 2023
Kana Matsumoto, Takuya Evan Kishimoto, Masami Yamamoto, Masaki Michishita, Kimimasa Takahashi, Hisashi Yoshimura. Apocrine carcinoma-and-malignant myoepithelioma in a dog: a case of simultaneous malignant progression of both luminal epithelium and myoepithelium. Journal of Veterinary Diagnostic Investigation. 2023
Masakazu Shimada, Tomokazu Nagashima, Masaki Michishita, Daisuke Yazawa, Yasushi Hara. Case report: Limb-sparing surgery of tibial chondrosarcoma with frozen autologous bone graft using liquid nitrogen in a dog. Frontiers in Veterinary Science. 2023. 10
Masanori Kobayashi, Moe Onozawa, Shiho Watanabe, Tomokazu Nagashima, Kyoichi Tamura, Yoshiaki Kubo, Akiko Ikeda, Kazuhiko Ochiai, Masaki Michishita, Makoto Bonkobara, et al. Establishment of a BRAF V595E-mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer. Veterinary and comparative oncology. 2023